Methylpiperazine

Methylpiperazine

SCHEMBL6016589

CN1CCN(c2ncc(C(=O)O)c(-c3ccc(F)cc3Cl)n2)CC1.CN1CCNCC1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.40
ALDH1A1 P00352 9/20 0.39
HSD17B10 Q99714 7/20 0.39
CYP3A4 P08684 6/20 0.39
TSHR P16473 5/20 0.39
CYP1A2 P05177 5/20 0.39
MAPK7 Q13164 2/20 0.39
KCNH2 Q12809 1/20 0.39
USP2 O75604 6/20 0.39
MAPK1 P28482 3/20 0.39
CYP2C9 P11712 3/20 0.39
HPGD P15428 1/20 0.39
HTR3A P46098 1/20 0.38
HIF1A Q16665 5/20 0.38
CASP1 P29466 4/20 0.38
CASP7 P55210 4/20 0.38
CYP2C19 P33261 1/20 0.38
GLA P06280 2/20 0.38
CYP2D6 P10635 1/20 0.37
PRKAB2 O43741 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016413 0.94 TACR1 (0.43) TACR1ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL6016520 0.92 ALDH1A1 (0.44) ALDH1A1HSD17B10CYP3A4TSHRCYP1A2
Piperazine SCHEMBL6016518 0.91 ALDH1A1 (0.44) ALDH1A1HSD17B10CYP3A4TSHRCYP1A2
Methylpiperazine SCHEMBL6016447 0.90 TACR1 (0.46) TACR1ALDH1A1HSD17B10CYP3A4TSHR
Methylpiperazine SCHEMBL6016601 0.86 HRH4 (0.44) TACR1ALDH1A1HSD17B10CYP3A4TSHR
Morpholine SCHEMBL6016412 0.85 PRKAB2 (0.49) ALDH1A1HSD17B10CYP3A4TSHRCYP1A2
Methylpiperazine SCHEMBL6016623 0.84 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP3A4TSHRCYP1A2
SCHEMBL4130912 0.84 TACR1 (0.50) TACR1ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL4119980 0.83 ALDH1A1 (0.42) TACR1ALDH1A1HSD17B10CYP3A4TSHR
Methylpiperazine SCHEMBL6016376 0.82 TSHR (0.46) TACR1ALDH1A1HSD17B10CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187815-B1 4-PHENYL-PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-02-08 EP disclosed
EP-1187815-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-03-20 EP disclosed
US-6274588-B1 NEUROKININ OR SUBSTANCE P ANTAGONISTS; CENTRAL NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. 2001-08-14 US disclosed
WO-2000073279-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-07 WO disclosed